Kinfo
Artivion Inc. logo

Artivion Inc.

AORTNYSEHealthcare·US · USD
$20.47
-0.17 (-0.82%)
Prices as of November 10, 2026 · market closed

Price

Key statistics

Valuation
Market cap1.01B USD
Enterprise value1.34B USD
Trailing P/E106.24
Forward P/E32.21
PEG ratio-0.10
Price / sales2.05
Price / book2.21
Profitability
Gross margin64.03%
Operating margin6.82%
Profit margin-3.65%
Return on assets1.93%
Return on equity-3.98%
Income (TTM)
Revenue481.88M USD
Gross profit305.08M USD
EBITDA44.06M USD
Net income-17.60M USD
Diluted EPS-$0.36
Rev. growth (YoY)9.20%
Balance sheet
Total cash48.40M USD
Total debt407.03M USD
Debt / equity91.18
Current ratio4.42
Book value / share$9.15
Cash flow (TTM)
Operating cash flow14.89M USD
Levered free cash flow-48.24M USD
Shares & price
Shares outstanding48.69M
Float46.36M
Held by institutions97.63%
Beta1.28
50-day MA$23.55
200-day MA$28.89
52-week high$48.25
52-week low$19.16
Dividends
Forward rate
$0.12
Yield
0.58%
Payout ratio
0.00%
Frequency
Quarterly
Recent payments
  • 2015-12-09$0.03
Earnings (EPS)
DateEst.ActualSurprise2026-11-050.070.08+14.29%2026-08-060.100.13+30.00%2026-06-090.480.22−54.17%2026-05-040.780.87+11.54%
About Artivion Inc.

Artivion Inc. is a medical device company focused on cardiac and vascular surgery, with a particular emphasis on the treatment of aortic disease. Artivion develops, manufactures, processes, and distributes a broad portfolio of products used in complex surgical procedures, including aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable human tissues for cardiac and vascular applications. Its offerings support surgeons in open, hybrid, and minimally invasive procedures, making the company a specialized supplier in advanced cardiovascular care. Artivion also provides tissue preservation services, extending its role beyond devices into biologic solutions used in transplant and reconstructive settings. With products sold across global markets, Artivion occupies an important niche in the medical technology sector centered on aortic repair and cardiovascular surgery.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. James Patrick Mackin
Employees
1,800
Headquarters
Kennesaw, GA, United States

Frequently asked questions about Artivion Inc.